Search

Author/Creator Chen, Sherry

1. Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3. (17th November 2022)

Authors:
Reich, Kristian; Simpson, Eric; Wollenberg, Andreas; Bissonnette, Robert; Abe, Masatoshi; Cardillo, Tracy; Janes, Jonathan; Sun, Luna; Chen, Sherry; Silverberg, Jonathan I
Journal:
British journal of dermatology
Issue:
Volume 188:Number 2(2023)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7. (20th January 2023)

Authors:
Silverberg, Jonathan I.; Simpson, Eric L.; Thyssen, Jacob Pontoppidan; Werfel, Thomas; Cardillo, Tracy E.; Colvin, Stephanie; Pierce, Evangeline; Chen, Yun‐Fei; Chen, Sherry; Eichenfield, Lawrence
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 5(2023)
Page Start:
1036
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Onset of Symptom Relief Reported in Daily Diaries of Patients With Atopic Dermatitis Treated With Baricitinib in a United States Clinical Trial (BREEZE-AD5). Issue 3 (May 2022)

Authors:
Rosmarin, David; Casillas, Marta; Chen, Sherry; Dawson, Zach; Pierce, Evangeline; Zhang, Hong; Bukhalo, Michael; Smith, Stacy
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 26:Issue 3(2022)
Page Start:
262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient and Family Advisory Councils for Research: Recruiting and Supporting Members From Diverse and Hard-to-Reach Communities. (October 2019)

Authors:
Harrison, James D.; Anderson, Wendy G.; Fagan, Maureen; Robinson, Edmondo; Schnipper, Jeffrey; Symczak, Gina; Carnie, Martha B.; Hanson, Catherine; Banta, Jim; Chen, Sherry; Duong, Jonathan; Wong, Celene; Auerbach, Andrew D.
Journal:
Journal of nursing administration
Issue:
Volume 49:issue 10(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study. Issue 4 (July 2022)

Authors:
Rosmarin, David; Fretzin, Scott; Strowd, Lindsay; Casillas, Marta; DeLozier, Amy M.; Dawson, Zach; Chen, Sherry; Lu, Na; Thyssen, Jacob P.
Journal:
Journal of cutaneous medicine and surgery
Issue:
Volume 26:Issue 4(2022)
Page Start:
377
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials. Issue 10 (30th March 2017)

Authors:
Fleisher, Adam S.; Joshi, Abhinay D.; Sundell, Karen L.; Chen, Yun‐Fei; Kollack‐Walker, Sara; Lu, Ming; Chen, Sherry; Devous, Michael D.; Seibyl, John; Marek, Kenneth; Siemers, Eric R.; Mintun, Mark A.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Issue 10(2017)
Page Start:
1117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗